公司資料
Armata Pharmaceuticals 股價、新聞與催化劑
- 股票代碼:
- ARMP
- 交易所:
- NYSE
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
5.10 USD (+15.38%)
收盤價
最後更新: 2026年8月21日
291M USD
市值
股價為何變動
As of Aug 21, 2026, ARMP closed up 15.4% at $5.10. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Armata Pharmaceuticals is a bacteriophage company focused on precision therapies for bacterial infections. Its platform aims to use phage biology to address resistant pathogens.
所在地與產業分類
Headquartered in the United States and listed on NYSE American, Armata sits in specialty biotechnology.
商業模式特徵
The company depends on clinical data, anti-infective differentiation, and the ability to build a durable phage-therapy story.
生技產業定位
Armata is a niche anti-infective catalyst name whose valuation depends on development progress.
未來催化劑
- Armata’s catalysts are phage-therapy programs, especially any update that shows the antibacterial platform can keep progressing. The market will care about whether the clinical path stays open.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。